Neuroone Medical Technologies Corp (NMTC) Stock Analysis

Neuroone Medical Technologies Corp (NMTC) is a publicly traded company in the HEALTHCARE sector. It trades at $3.56, carries a market capitalization of $32.07M. This page summarizes the public market data, fundamentals, and frequently asked questions for NMTC, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $3.56
• Market Cap: $32.07M
• EPS: $-0.89
• 52-Week High: $6.96
• 52-Week Low: $3.28

Market Sentiment

Neuroone Medical Technologies Corp currently has a Neutral sentiment score of 0.06.

About Neuroone Medical Technologies Corp

NeuroOne Medical Technologies Corporation (NMTC) is a pioneering medical technology firm headquartered in Eden Prairie, Minnesota, dedicated to revolutionizing the treatment of neurological disorders through the development of advanced implantable devices and neuromodulation solutions. The company targets significant unmet clinical needs, particularly in the management of epilepsy and chronic pain, utilizing its proprietary technologies to enhance patient care and outcomes. With a robust focu...

GNG Research Analysis

GNG Research scores Neuroone Medical Technologies Corp (NMTC) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for NMTC.

Frequently Asked Questions

Does NMTC pay dividends?

Neuroone Medical Technologies Corp (NMTC) does not currently pay a regular dividend.

What is NMTC's market cap?

Neuroone Medical Technologies Corp (NMTC) has a market capitalization of $32.07M with a current stock price of $3.56.